Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer.

Autor:	Weidner P; Department of Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Söhn M; Department of Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Gutting T; Department of Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Friedrich T; Department of Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Gaiser T; Institute of Pathology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Magdeburg J; Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Kienle P; Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Ruh H; ABIMAS Research Center, Mannheim University of Applied Sciences, D-68163 Mannheim, Germany., Hopf C; ABIMAS Research Center, Mannheim University of Applied Sciences, D-68163 Mannheim, Germany., Behrens HM; Institute of Pathology, Christian Albrecht University, D-24105 Kiel, Germany., Röcken C; Institute of Pathology, Christian Albrecht University, D-24105 Kiel, Germany., Hanoch T; Department of Biological Regulation, Weizmann Institute of Science, I-7610001 Rehovot, Israel., Seger R; Department of Biological Regulation, Weizmann Institute of Science, I-7610001 Rehovot, Israel., Ebert MP; Department of Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany., Burgermeister E; Department of Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany.
Jazyk:	angličtina
Zdroj:	Oncotarget [Oncotarget] 2016 Aug 02; Vol. 7 (31), pp. 50490-50506.
DOI:	10.18632/oncotarget.10466
Abstrakt:	Phosphoinositide (PIP) phosphatases such as myotubularins (MTMs) inhibit growth factor receptor signaling. However, the function of myotubularin-related protein 7 (MTMR7) in cancer is unknown. We show that MTMR7 protein was down-regulated with increasing tumor grade (G), size (T) and stage (UICC) in patients with colorectal cancer (CRC) (n=1786). The presence of MTMR7 in the stroma correlated with poor prognosis, whereas MTMR7 expression in the tumor was not predictive for patients' survival. Insulin reduced MTMR7 protein levels in human CRC cell lines, and CRC patients with type 2 diabetes mellitus (T2DM) or loss of imprinting (LOI) of insulin-like growth factor 2 (IGF2) had an increased risk for MTMR7 loss. Mechanistically, MTMR7 lowered PIPs and inhibited insulin-mediated AKT-ERK1/2 signaling and proliferation in human CRC cell lines. MTMR7 provides a novel link between growth factor signaling and cancer, and may thus constitute a potential marker or drug target for human CRC. Competing Interests: The authors have nothing to declare.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu